Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus

Clinical Gastroenterology and Hepatology

Volumn 1, Issue 4, 2003, Pages 258-263

  Attwood, Stephen E A ^a   Lewis, Christopher J ^a   Caplin, Scott ^a   Hemming, Karla ^b   Armstrong, Gordon ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; DYSPLASIA; ENDOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; SAFETY; TREATMENT OUTCOME;

EID: 0141920695     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(03)00128-9     Document Type: Article

References (38)

1. DeMeester TR. Surgical therapy for Barrett's esophagus: prevention, protection and excision. Dis Esophagus 2002;15:109-116.
2. Overholt BF. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia. Am J Manag Care 2000;6:S903-S908.
3. Altorki NK, Sunagawa M, Little AG, Skinner DB. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97-100.
4. Sharma P. Controversies in Barrett's esophagus: management of high grade dysplasia. Semin Gastrointest Dis 2001;12:26-32.
5. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:613-634.
6. Case CL, Barkin JS. The approach to high grade dysplasia in Barrett's esophagus. Am J Gastroenterol 2002;97:1559-1560.
7. Collard JM. High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg Clin N Am 2002;12:77-92.
8. Banki F, Mason RJ, DeMeester SR, Hagen JA, Balaji NS, Crookes PF, Bremner CG, Peters JH, DeMeester TR. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002;236:324-336.
9. Gerzic ZB. Modification of the Merendino procedure. Dis Esophagus 1997;10:270-275.
10. Fernando HC, Luketich JD, Buenaventura PO, Perry Y, Christie NA. Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur J Cardiothorac Surg 2002;22:1-6.
11. Nguyen NT, Schauer P, Luketich JD. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery 2000;127:284-290.
12. Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, Henrich R, Vieth M, Muller H, Seitz G, Stolte M. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-677.
13. Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998;93:1810-1815.
14. Kelty C, Marcus S, Ackroyd R. Photodynamic therapy for Barrett's esophagus: a review. Dis Esophagus 2002;15:137-144.
15. Javaid B, Watt P, Krasner N. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study. Lasers Med Sci 2002;17:51-56.
16. Overholt BF, Panjehpour M, Haydek J. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7.
17. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, Seidel UJ, Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-1619.
18. Overholt BF, Haggit RC, Bronner MP, Hao Y. A multicentre, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): results of 6-months follow-up. Gastroenterology 2001;120:425.
19. Morris CD, Byrne JP, Armstrong GR, Attwood SE. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation. Br J Surg 2001;88:1357-1362.
20. Hakulinen T, Abeywickrama K. A computer program package for relative survival analysis. Comput Prog Biomed 1985;19:197-207.
21. Ormsby A, Petras R, Henricks W, Richter J. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002;51:671-676.
22. Falk GW, Rice TW, Goldblum JR, Richter J. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high grade dysplasia. Gastrointest Endosc 1999;49:170-176.
23. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670-680.
24. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-859.
25. Hameeteman W, Tytgat G, Houthoff H, van den Tweel J. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-1256.
26. Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am J Gastroenterol 2001;96:990-996.
27. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
28. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303-321.
29. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999;94:2043-2053.
30. Alderson D. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma: another spanner in the works? Gut 2002;51:620-621.
31. Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart U. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001;120:1630-1639.
32. Edwards MJ, Gable DR, Lentsch AB, Richardson JD. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996;223:585-591.
33. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
34. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-1836.
35. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992;54:199-204.
36. Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and non-surveyed patients. J Thorac Cardiovasc Surg 1994;108:813-822.
37. Sampliner RE, Fennerty MB. Laser therapy of Barrett's mucosa. Gastrointest Endosc 1993;39:209-210.
38. Salo JA, Salminen JT, Kiviluoto TA, Nemlander AT, Ramo OJ, Farkkila MA, Kivilaakso EO, Mattila SP. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 1998;227:40-44.